Meningitis outbreak spreads to second university in Kent after vaccine supplies dwindle

Meningitis outbreak spreads to second university in Kent after vaccine supplies dwindle

A new meningitis case has emerged at Canterbury Christ Church University (CCCU), marking the second institution in Kent affected by the outbreak. The initial cluster was linked to Club Chemistry, a nightclub where a fresher’s event drew sixth formers, sparking a ‘super-spreader’ situation.

National incident declared as cases surge

Health officials have escalated the meningitis outbreak to a national incident, with the number of confirmed cases rising. The University of Kent is administering meningitis B vaccines to all students residing on campus, aiming to prevent further spread. Symptoms of the infection can develop between two and 14 days post-exposure, prompting concerns about rising numbers.

“The UK Health Security Agency (UKHSA) has confirmed one case of meningococcal disease at CCCU, connected to the initial cluster at Club Chemistry,” said Rama Thirunamachandran, the university’s vice-chancellor. “We’ve directly supported the affected individual and are monitoring the situation closely.”

UKHSA chief executive Susan Hopkins highlighted the outbreak’s rapid spread, noting: “This is a super-spreader event, with infections continuing to spread within university residences. There were significant social gatherings around this time, leading to intense mixing. I can’t yet determine the origin of the initial infection or why it’s caused such an explosive surge in cases.”

Experts call the outbreak unprecedented, citing the high volume of cases emerging in a short timeframe. NHS initially treated it as a major regional incident, but the situation has now prompted national-level oversight. GPs across the UK have been instructed to prescribe antibiotics to anyone who attended Club Chemistry between March 5-7.

Vaccine shortages strain pharmacies and healthcare systems

Private stocks of meningitis B vaccines have depleted, leaving pharmacies in a precarious position. Boots has introduced a queueing system for vaccinations, warning of high demand, while Superdrug reports a waiting list due to a ‘national shortage.’

According to the National Pharmacy Association, pharmacy bookings for the vaccine are currently offline, with a message stating: “We’ll be back shortly. Demand for the Meningitis B Vaccination Service is currently high and we’re having a few technical difficulties. We’re trying to get through as soon as we can.”

Health officials urge individuals not to skip antibiotics if prescribed, as a single tablet of Ciprofloxacin can reduce the risk of meningitis in a household by up to 90%. Six confirmed cases have been classified as group B meningococcal disease, with one individual traced to London, where they visited a hospital without community contacts.

A baby girl is hospitalized with the same meningitis strain, though her case is not currently tied to the Kent outbreak. With thousands of students in the region receiving preventative treatment, the focus remains on controlling the spread and addressing vaccine supply challenges.